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SINTESIS, STRUKTUR HABLUR DAN AKTIVITI 
ANTIBAKTERIA KOMPLEKS BAHARU ARGENTUM(I) N-
HETEROSIKLIK KARBENA YANG BUKAN DAN 
BERFUNGSIAN NITRIL 
 
 
ABSTRAK 
 
 Dua siri baru garam benzimidazolium benzil bergantian iaitu bukan berfungsi 
(1-3·PF6 and 7-9·2PF6) dan berfungsian nitril (4-6·PF6 and 10-12·2PF6) telah berjaya 
di sintesis sebagai pelopor untuk N-heterosiklik karbena (NHC). Tindak balas antara 
garam benzimidazolium dan argentum(I) oksida dengan kadar bersesuaian telah 
memudahkan garam benzimidazolium untuk berdeprotonasi in situ yang 
mendapatkan dua siri kompleks argentum(I)-NHC, [Agn(L)2]·nPF6 (Ag1-Ag12), 
masing-masing (di mana L = 1-6: 1-(2’/3’/4’-metilbenzil/metilbenzonitril)-3-(2’’-
propil)benzimidazolium, n = 1 atau L = 7-12: 3,3-(butana-1,4-diyl)-1,1-(2’/3’/4’-
metilbenzil/metilbenzonitril)bisbenzimidazolium, n = 2). Kegunaan satu kompleks 
argentum(I)-NHC, Ag1 sebagai ejen pemindahan telah berjaya dilihat di dalam 
pembentukan kompleks palladium(II)-NHC, Pd1 yang telah berformula sebagai 
[PdCl(L)2(MeCN)]PF6 (di mana L = 1: 1-(2’-metilbenzil)-3-(2’’-
propil)benzimidazolium). Kedua-dua garam benzimidazolium dan kompleks logam-
NHC telah dicirikan menggunakan analisis tahap lebur, teknik analisis unsur, 
spektroskopi FT-IR dan spektroskopi
  1
H dan 
13
C NMR. Spektra 
1
H NMR kompleks 
adalah lebih kurang serupa dengan sebatian garam masing-masing tetapi signal bagi 
xxii 
 
proton H2’ benzimidazolium telah hilang sepenuhnya dan mencadangkan 
pengkompleksan yang berjaya. Dalam kes spektrum 
13
C NMR kompleks, resonans 
karbon C2’ telah muncul di kawasan medan rendah (lebih kurang 185 ppm) 
mengesahkan pembentukan kompleks. Struktur molekul untuk sebahagian sebatian 
dan kompleks telah dikenalpasti melalui teknik pembelauan sinaran-X hablur 
tunggal. Analisis stuktur mendapati bahawa di dalam ketiadaan sebarang ikatan 
hidrogen yang berpotensi sebagai penderma dan penerima, pelbagai interaksi 
supramolekular memainkan peranan penting dalam menstabilkan seluruh struktur. 
Oleh itu, mengikut semua data-data yang didapati, semua garam benzimidazolium 
dan kompleks logam-NHC telah berjaya disintesis. Kajian antibakteria melawan 
bakteria Gram-negatif Escherichia coli (ATCC 25922) dan bakteria Gram-positif 
Staphylococcus aureus (ATCC 12600), telah dijalankan ke atas semua garam 
benzimidazolium dan kompleks logam-NHC yang telah disintesis menggunakan 
kaedah bersesuaian. Kesemua garam benzimidazolium menunjukkan keputusan 
negatif dalam kajian ini manakala aktiviti antibakteria untuk kesemua logam-NHC 
berbeza mengikut keadaan ligan. Semua kompleks mononuklear argentum(I)-NHC 
mempamerkan aktiviti antibakteria yang sederhana manakala kompleks dinuklear 
argentum(I)-NHC adalah rendah dalam aktiviti berbanding antibiotik standard, 
ampicillin. Kompleks palladium(II)-NHC, Pd1 hanya menunjukkan aktiviti yang 
rendah melawan S. aureus berbanding Ag1 dan ampicillin. 
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SYNTHESIS, STRUCTURAL ANALYSES AND 
ANTIBACTERIAL ACTIVITIES OF NEW NON-
FUNCTIONALIZED AND NITRILE FUNCTIONALIZED 
SILVER(I) N-HETEROCYLIC CARBENE COMPLEXES 
 
 
ABSTRACT 
 
 Two series of new benzyl substituted benzimidazolium salts, both non-
functionalized, (1-3·PF6 and 7-9·2PF6) and nitrile-functionalized, (4-6·PF6 and 10-
12·2PF6) were successfully synthesized as N-heterocyclic carbene (NHC) precursors. 
The reaction of an appropriate ratio of respective benzimidazolium salts with 
silver(I) oxide facilitated the in situ deprotonation of the benzimidazolium salts  that 
afforded the formation of two series of silver(I)-NHC complexes, [Agn(L)2]·nPF6 
(Ag1-Ag12), (where L = 1-6: 1-(2’/3’/4’-methylbenzyl/methylbenzonitrile)-3-(2’’-
propyl)benzimidazolium, n = 1 or L = 7-12: 3,3-(butane-1,4-diyl)-1,1-(2’/3’/4’-
methylbenzyl/methylbenzonitrile)bisbenzimidazolium, n = 2). The uses of one of the 
silver(I)-NHC complex, Ag1 as a transfer agent was successfully observed in the 
formation of a palladium(II)-NHC complex, Pd1 formulated as 
[PdCl(L)2(MeCN)]PF6 (where L = 1: 1-(2’-methylbenzyl)-3-(2’’-
propyl)benzimidazolium). Both the benzimidazolium salts and metal-NHC 
complexes were characterized by melting point analysis, elemental analyses, FT-IR 
spectroscopy and 
1
H and 
13
C NMR spectroscopy. The 
1
H spectra of complexes are 
rather similar to those of the respective salts with the signal for the benzimidazolium 
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H2’ proton completely absent suggesting successful complexation. In the case of 13C 
NMR spectra of the complex, C2’ carbon resonance appeared as doublets in the 
downfield region (ca. 185 ppm) confirming the complex formation. The molecular 
structures of some of the compounds and complexes were established by single 
crystal X-ray diffraction analyses. Structural analysis indicated that in the absence of 
any potential hydrogen bond donors or acceptors, various supramolecular 
interactions played an important role in stabilizing the entire structure. Hence, via all 
the data obtained, the benzimidazolium salts and metal-NHC complexes were 
successfully synthesized. Antibacterial studies against a Gram-negative bacteria 
Escherichia coli (ATCC 25922) and a Gram-positive bacteria Staphylococcus aureus 
(ATCC 12600), were carried out for all the synthesized benzimidazolium salts and 
metal-NHC complexes using established methods. All the benzimidazolium salts 
were inactive while the antibacterial activity of the metal-NHC complexes varied 
depending on the nature of the ligands. All the mononuclear silver(I)-NHC 
complexes exhibited medium antibacterial activities while dinuclear silver(I)-NHC 
complexes were low in the activities compared to the standard antibiotic, ampicillin. 
The palladium(II)-NHC complex, Pd1 showed only low activities againts S. aureus 
compared to Ag1 and ampicillin. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Carbene and N-heterocyclic carbene 
Carbene is a type of carbon intermediate that contains a divalent carbon 
atom. Carbene carbon is bonded to two adjacent groups by covalent bonds, and the 
other two electrons are present as nonbonding electrons (Figure 1.1).
1
 These three 
groups allow an sp
2
 hybridization for the carbene carbon, with a plane occupied by 
the C and two R groups and a vacant p orbital extending above and below the 
plane. The remaining one pair of electron occupies an sp
2
 hybrid orbital. These 
electrons may have antiparallel spins (singlet spin) or parallel spins (triplet state). 
 
 
(a)                     (b) 
Figure 1.1: (a) General structure of carbene. (b) Examples of carbenes. 
 
The possibility of carbene being  in the singlet state or triplet state depends 
on the difference in energy between its frontier orbitals. As the energy increases in 
difference, the singlet state becomes more likely because the higher the energy, the 
less the tendency of the frontier molecular orbital to be occupied. On the other 
hand, triplet state is favoured in ground state if the energy difference is low (Figure 
1.2).
2
  
 
2 
 
CC
Singlet Triplet  
Figure 1.2: The ground state of carbene. 
 
Carbenes are classified according to their reactivity towards metal ions. 
The first type of carbenes, namely Fischer carbenes appeared as singlet carbenes 
with electrophilic character. These carbenes having σ electrons will donate the 
electron pair from sp
2
 orbital and the  empty p-orbital will accept back donations 
from the metal in π mode (Figure 1.3). The first stable Fischer carbene complex 
with tungsten(0) was successfully synthesized in 1964 (Scheme 1.1).
3
  
 
M C
R'
R
:
:
Singlet
 
Figure 1.3: Bonding in Fischer carbene complexes. 
 
 
Scheme 1.1: Synthesis of first stable Fischer complex.
3 
 
 The second type of carbene was reported one decade after the discovery of 
Fischer carbenes. Known as Schröck carbenes, these carbenes were considered as 
triplet carbenes with nucleophilic character. Schröck carbenes have two unpaired 
electrons and these electrons interacted with metal to form two covalent bonds 
3 
 
(Figure 1.4). The first stable Schröck carbene was discovered by Schröck in 1974 
(Scheme 1.2).
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Figure 1.4: Bonding in Schröck carbene complexes. 
 
 
Scheme 1.2: Synthesis of first stable Schröck carbene.
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Different from Fischer and Shröck carbenes, N-heterocyclic carbenes 
(NHC) are singlet carbenes with neutral character. The contribution of the 
electronegativity of the nitrogen atoms make the NHC appear as a singlet state 
carbene.  Also known as Arduengo’s carbenes, these cyclic carbenes are usually 
derived from the deprotonation of azolium salts using strong base. The electron 
pair of the carbene occupies the σ-orbital and will be donated to the metal by 
forming a single dative bond with the metal. The resulting empty p-orbital of 
carbene carbon will receive electron density from the lone pair electrons of both 
adjacent nitrogen atoms (Figure 1.5). 
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Figure 1.5: Bonding in NHC complexes.
 
 
The history of the NHCs chemistry began with research done by Wanzlick 
around 1960s,
5
 but in 1991, the first stable crystalline free NHC, 1,3-di-(1-
adamantyl)imidazol-2-ylidene (1.1) was isolated by Arduengo and co-workers.
6
 
This isolation was done via deprotonation of 1,3-di(adamantyl)imidazolium 
chloride with sodium hydride (Scheme 1.3). In the absence of oxygen and 
moisture, this carbene was found to have a unique stability at room temperature. 
 
C:
N
N
N
N
H
Cl-
NaH, THF
cat. DMSO
 
   (1.1) 
Scheme 1.3: The synthesis of 1, 3-di-(1-adamantyl)imidazol-2-ylidene (1.1).
6 
 
NHCs owed their powerful stability due to the adjacent nitrogen atoms 
that afford a unique electronic structure.
7
 This interaction was called pull and push 
stabilization. The “pull” stabilization (Figure 1.6(a)) due to the σ-bonding between 
the carbene carbon with the two electronegativity of nitrogen atoms while the 
5 
 
“push” stabilization (Figure 1.6(b)) is because of the two πN→πC donor interactions 
from the electron pairs on the nitrogen into the empty p-orbital of the carbene 
carbon.
8
 However, this electronic structure made NHC good σ-donor but poor π-
acceptor ligands.
9 
 
Push 
e- density
Pull
e- density  
(a)       (b) 
Figure 1.6: (a) pull interaction and (b) push interaction in NHCs. 
 
1.2 Benzimidazole and benzimidazolium salts 
 With the formula C6H4N2HCH, benzimidazole is one of the heterocyclic 
cores of NHC other than imidazole, pyrazole, triazole and tetrazole.
10
 
Benzimidazoles are heterocyclic compounds in which benzene is fused with five 
membered ring containing two heteroatoms. Both heteroatoms are nitrogen (N), 
which are present at non-adjacent position.
11
 The position of hydrogen atom can be 
either at nitrogen position 3 or 1 (Figure 1.7), and this allows benzimidazole exist 
in two equivalent tautomeric forms 1H- and 3H-benzimidazole. 
 
N
H
N1
2
34
5
6
7
8
9
 
Figure 1.7: The numbering in benzimidazole. 
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Benzimidazolium salts are formed easily from the protonation or by the 
attachment of a wide variety of groups onto positions 1- and 3- of the ring.
12
 When 
a benzimidazolium salt has substitutions on both of its nitrogen atoms, this salt 
behaves like quaternary ammonium salts and organic base hydrochlorides.
8,13 
When 
an acidic proton from a benzimidazolium ion is removed by a strong base, the NHC 
can be formed (Scheme 1.4)  
 
N
N
R
R
H Base C:
N
N
R
R
benzimidazolium ion benzimidazol-2-ylidene 
Scheme 1.4: The base deprotonation resulting in a singlet state NHC. 
 
For more than five decades, imidazole and benzimidazole derived NHC 
precursors have been known in the area of organometallic chemistry and 
imidazole-based derivatives may have been the first NHC precursors ever used by 
the organometallic chemists.
14
 With the abundance of transition/inner transition 
metal ions in different oxidation states, the organometallic chemistry of NHCs 
especially imidazole and benzimidazole, varies widely.
15
  
Benzimidazolium salts also have been reported to poses antithrombotic, 
herbicidal, anthelmintic and catalytic properties since the past few years.
16
 
Recently, the synthesis of benzimidazole derivatives have been found to have 
pharmacological activities such as antitumour, anti-ulcer, antibacterial, and 
antifungal properties.
17
 There are many antibacterial and antifungal drugs used in 
the treatment of bacterial and fungal infections but some of them have desirable 
side effect.
18
 Hence, this type of NHC is easy to synthesis in a few steps, the 
7 
 
substituent can be easily changed and their reactivity in biological medium can be 
easily be manipulated.
19
  
 
1.3 Synthetic method of metal-NHC complexes 
An NHC complex is where the free electrons pair of carbene carbon is 
donated to the metal atom and this electron deficiency is stabilized by electron 
from nitrogen atom next to carbene carbon.
20
 There are many methods that can be 
used to synthesise metal complexes of NHC. The three major routes are: 
 
1.3.1 Free carbene method 
The free carbene method is one of the method that been used to synthesis 
the metal NHC complexes, especially containing silver(I)- and mercury(II)-NHC 
complexes.
23 
These reactions can be done by leaving the azolium salts to react with 
a strong base such as potassium tert-butoxide, sodium hydride and lithium 
bis(trimethyl)amide
6
 to prepare a free NHCs, in which later the metal sources are 
then added. These free carbenes can be isolated or used without isolation by this 
method. The first silver(I)-NHC complex was reported by Arduengo and co-
workers in 1993 using free carbene method after their success in obtaining the 
aforementioned free carbene (1.1) and carbene (1.2).
7
 The formed silver(I)-NHC 
complex (1.3) was obtained by the reaction of silver(I) triflate with two equivalents 
of the NHC ligand (1.2), in THF under a dry nitrogen atmosphere (Scheme 1.5). 
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C:
N
N
AgOSO2CF3 N
N
Ag+
N
N
CF3SO3
-
 
     (1.2)      (1.3) 
Scheme 1.5: Synthesis of first silver(I)-NHC complex (1.3) by Arduengo and co-
workers.
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Using this method, there are large variety of metal-NHC without special 
requirement can be synthesized, however, the free NHC can face some problems as 
the NHC ligands may decompose as this type of ligand are known to be sensitive to 
air and moisture as well as thermally sensitive.
24
 Sometimes dimerization of the 
free NHC ligands (Wanzlick equilibrium) may occur before they react with a metal 
source (Scheme 1.8).
25
  
 
1.3.2 In-situ deprotonation 
With many apparent limitations of the free carbene method, alternative 
synthetic methods for the synthesis of the metal-NHC complexes have been 
developed. The most popular method is the in-situ deprotonation method 
introduced by Öfele in 1968.
22
 In this method, there are two kinds of in-situ 
reactions. First method is by using basic metal complexes reagent such as silver(I) 
oxide,
26
 mercury(II) acetate
21 
and palladium(II) acetate.
27,28
 For example, in 
Scheme 1.9, the acetate from the palladium(II) acetate was used to attract an acidic 
proton from the carbene precursor, and the resulting carbene is trapped by 
9 
 
palladium from the same metal source to form the desired palladium(II)-NHC 
complex (1.4) (Scheme 1.6).
  
 
N
N
Ph
Ph
Ph
Ph
Br-
Pd(OAc)2
N
N
Ph
Ph
Ph
Ph
Pd
Br
Br
N NR
O
R = benzhydryl
 
     (1.4) 
Scheme 1.6: Pd(OAc)2 as a base and metal source.
28 
 
 The second type of in-situ deprotonation in the formation of NHC 
complexes is by using the external base to deprotonate NHC salts. The strong bases 
in this reaction including potassium tert-butoxide, lithium tert-butoxide,
29
 and 
sodium acetate
30
 will deprotonate the NHC salts before the metalation occur using 
metal from other metal source by choice. For example, palladium(II)-NHC 
complexes (1.5) was obtained by the extraction of acidic proton by external base, 
sodium acetate then the carbenes were trapped by palladium from palladium(II) 
chloride (Scheme 1.7).
30 
 
PdCl2, NaOAc, DMSO
N
N
PPh2
Cl-
N
N
R
R
PPh2
Pd
Cl
Cl
 
      (1.5) 
Scheme 1.7: The example of in-situ deprotonation using external base, NaOAc 
before treating with metal source, PdCl2.
3 
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1.3.3 Transmetallation (NHC Transfer) 
Transmetallation or carbene transfer method is where a NHC is transferred 
from one metal centre to another. Carbene transfer reaction between metal ions was 
first investigated by Fischer and Bech.
31
 Later in 1998, Liu and co-workers 
introduces the transfer of NHC reaction from tungsten(0) to palladium(II)-NHC 
and platinum(II)-NHC. In their reaction, palladium(II)-NHC complex (1.7) was 
yielded when the tungsten(0)-NHC complex (1.6a) was treated with 0.5 mole 
equivalent of (PhCN)2PdCl2 (Scheme 1.8) while (1.8) and (1.9) was obtained when 
(1.6b) was left to react with 1 equivalent of same palladium source, (PhCN)2PdCl2 
and platinum source, (PhCN)2PtCl2 (Figure 1.8).
32 
This method was then extended 
to produce rhodium(I)- and gold(I)- NHC complexes from tungsten(0)- and 
molybdenum(0)-NHC complexes as the transfer agents.
33
 
 
N
N
R
R
W(CO)5
(PhCN)2PdCl2
N
N
Pd N
N
Cl Cl
R
R
R R
 
 (1.6a) R= -CH2CHCH2    (1.7) 
 (1.6b) R= -CH2CH3 
Scheme 1.8: Transmetallation reaction to produce palladium(II)-NHC (1.7) using 
tungsten(0)-NHC (1.6a) as transfer agent.
32 
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   (1.8)     (1.9) 
    (a)      (b) 
Figure 1.8: (a) Palladium(II)-NHC complex (1.8) and (b) platinum(II)-NHC 
complex (1.9) from reaction of (1.6b) with respective metal sources.
32 
 
1.4 Application of metal-NHC complexes 
1.4.1 Catalysis studies 
 NHC become crucial ligands in homogenous catalysis since the isolation of 
free carbene in 1991.
6
 In 1996, Grubbs and co-worker conducted a research on 
olefin methathesis reaction using ruthenium alkylidene diphosphine complexes, 
(1.10) and (1.11), which were known as the first generation Grubbs catalysts 
(Figure 1.9).
34-36 
Later, the second generation Grubbs catalyst, for example (1.12) 
where phosphine was replaced by an NHC ligand for alkene metathesis were 
developed (Figure 1.10).
37,38 Later, more ruthenium(II)-NHC complexes were 
isolated, showing more activity with selectivity in the reactions. Other than that, the 
uses of palladium(II)-NHC complexes in C-C bond forming reactions such as Heck 
and Suzuki couplings,
20,39-45 
iridium(III)-NHC catalysed hydrogenation and 
hydrogen transfer,
46-48 
platinum(II)-NHC catalysed hydrosilation,
49
 mercury(II)-
NHC in Hofmann elimination reaction,
50
 nickel(II)-NHC catalysed polymerisation 
reactions,
51-56 
and rhodium(I)-NHC catalysed hydroboration
57
 proved the powerful 
uses of NHC metal complexes in catalysis activity. 
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       (1.10)          (1.11) 
Figure 1.9: The first generation of Grubbs catalyst. 
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(1.12) 
Figure 1.10 The example of second generation of Grubbs catalyst. 
 
1.4.2 Carbene transfer chemistry 
In 1998, Wang and Lin have reported their gold(I)- and palladium(II)-NHC 
complexes, (1.15 and 1.16) respectively, obtained from the respective silver(I)-
NHC (1.15) as a transfer agent (Scheme 1.9).
26
 After the discovery, many 
complexes such as palladium(II)-, platinum(II)- ruthenium(II)- and rhodium(I)-
NHC complexes have been synthesized using transmetallation from silver(I) 
complex.  
13 
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(1.14)
(1.15)
(1.16)
(1.13)
 
Scheme 1.9: Reaction by Wang and Lin to produce silver(I)-, gold(I)- and 
palladium(II)-NHC complexes.
26 
 
Carbene transfer method from silver complexes becomes an alternative route 
when dealing with NHC precursors that have acidic functional groups. This groups 
can interfere when preparing the desired complexes via conventional methods. For 
example, McGuiness and Cavell used this method to prepare a series of 
palladium(II)-NHC complexes because their attempts in preparing same complexes 
failed using in situ deprotonation (Scheme 1.10). This is due to the presence of 
acidic methylene protons in the substituent attached to their imidazolium salts that 
caused the interferences in the extracting the carbene proton by palladium(II) 
acetate.
58
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Scheme 1.10: General schematic diagram of preparation of palladium(II)-NHC 
complexes from silver(I)-NHC complexes by Guiness and Cavell.
58 
 
This method also avoids the formation of free NHC and the possibility of the 
NHC to decompose is low. However, there is some drawback in this method where 
there will be formation of product with low yield and sometimes the transmetalate 
unsuccessful. The NHC with saturated backbones have been shown to be relatively 
poor transmetalation reagents when compared to NHC with unsaturated backbones. 
Despite, the succesful transmetalation of saturated silver(I)-NHC complexes is also 
dependent upon the other metal source used.
59
 Other than silver(I)-NHC, 
mercury(II)-NHC can also be used as a ligand transfer agent. Transfer of NHC 
ligands from mercury(II)-NHC to transition metals and main group element such as 
sulphur, selenium and tellurium have been achieved by this method.
60
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1.4.3 Biological activities and medicinal chemistry 
 Metal-NHC complexes have been widely studied for their catalytic 
properties, but their potential as biologically active agents still remain unexplored. 
In the past few years, biological studies such as antimicrobial and anticancer 
studies remain as an active research area because many silver(I)-,
61-65
 gold(I)-,
16,66
 
copper(I)-,
67
 ruthenium(II)-
68
 and rhodium(I)-
67,69
 NHC complexes have shown 
very excellent potential in these applications. Recently,  palladium(II)-
70
 and 
selenium-
71
 NHC complexes also showed their potential as a good anticancer 
agents. 
 
1.5  Silver(I)-NHC complexes 
 Silver(I)-NHC is interested to researchers due to the simpler synthetic 
strategies, structural diversity, stability, and their wide range of applications. 
Silver(I)-NHC complexes have been observed to be very stable in air and moisture, 
and can be prepared efficiently.
72
 There are three common ways to synthesize 
silver(I)-NHC complexes. First method to produce the desired complexes is by the 
treatment of free NHCs with appropriate silver source, normally at liquid nitrogen 
temperature. As mentioned in Section 1.3(i), this free NHC method was used to 
synthesise the first silver(I)-NHC complex by Arduengo in 1993.
7 
 Although the desired silver(I)-NHC complexes can be prepared using free 
NHC method, but some inconveniences may be faced by these free NHCs.
25
 
Hence, several research groups discovered the second method in which the 
silver(I)-NHC complexes could be synthesized from the reaction of imidazolium 
salts and silver bases by in-situ method. The uses of silver bases start in 1997, in 
which the silver acetate was used in the synthesis of a silver(I)-NHC complexes 
16 
 
from triazolium salts.
73
 A year after, in 1998, Wang and Lin reported the used the 
silver oxide (Scheme 1.11)
26 
while in 2000, silver carbonate was introduced to 
produce silver(I)-NHC complexes.
74
 Among all the silver sources, silver(I) oxide 
are the most commonly used because it is relatively stable, commercially 
accessible, the reaction can be carried out in one-pot reaction at room temperature, 
solvent pretreatment, strong bases are not required and chirality can be retained.
75
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  (1.13)              (1.14) 
Scheme 1.11: The silver(I)-NHC complex synthesized by Wang and Lin.
26 
  
 The third way is by the treatment of silver salts with azolium salts under 
basic phase-transfer conditions introduced by Wang and Lin in 1998.
26
 In this 
reaction, the complex (1.18) was synthesized by the reaction of benzimidazolium 
bromide (1.17) with AgBr with the present of strong base (Scheme 1.12). 
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+Br-, NaOH
Br  
     (1.17)          (1.18) 
Scheme 1.12: Reaction of silver salts and azolium salts in presence of base.
26 
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1.6 Silver(I)-NHC complexes as carbene transfer agent 
 Nowadays, silver(I)-NHC complexes are famously known because of their 
biological activities and as the carbene transfer agents in transmetallation studies. It 
is common to know about several methods to synthesis silver(I)-NHC complexes 
by conventional methods 
25,26,73,74
 as mentioned before but for preparing other 
carbene metals, the most popular approach is by transmetallation of NHCs from 
silver(I)-NHC complexes.
15 
In this method, the synthesized silver(I)-NHC complex 
was reacted with other metal sources by choice. The first uses of silver(I)-NHC as a 
transfer agent was by Wang and Lin 1998 who prepared palladium(II)- and gold(I)-
NHC.
26
 In this reaction, the reported azolium salts was treated with Ag2O to get the 
silver(I)-NHC complexes which then act as NHC transfer agents. Furthermore, the 
resulted silver(I)-NHC complex was let to react with other metal source to transfer 
the NHC ligand and the targeted metal-NHC complex was produced (Scheme 1.9). 
 
1.7 Biological activities of silver(I)-NHC complexes 
 Other than their ability as NHC transfer agent, silver(I)-NHC complexes 
have also received many attention from researchers because of their biomedical 
applications such as anticancer as well as antimicrobial agents against numerous 
pathogens. Silver is not a natural metal in human body, but previous studies proved 
that they are relatively low toxic to human
76
 but highly toxic to most 
microorganisms
77,78
 and it showing strong biocidal effects on as many as 16 species 
of bacteria including E. coli.
79
 The slow release of silver ions from the silver NHC 
complexes into the infected site could obtain better prevention of infection and 
promote healing. The inability of some of the current silver antimicrobial agents to 
kill the pathogens in a suistained period of time being a basic challenge and the 
18 
 
slow release ability of the silver NHC complexes can be used to solve this 
problem.
80,81
 Other than that, silver is also known for its potential in anticancer 
studies.
16,62,71,82,83
 For example in 2008, Youngs and co-workers have synthesized 
several silver(I)-NHC complexes and later, this complexes were tested and proved 
their potential againtst the human derived ovarian (OVCAR-3), breast (MB157), 
and cervical (HeLa).
84
 
 
1.8 Silver(I) complexes with functionalized benzimidazole-derived NHC 
 In recent years, many researchers have been interested in the chemistry of 
silver complexes with functionalized NHC ligands due to their extra stability which 
could led to diverse applications. These functionalized NHCs possessed a versatile 
class of carbene ligands with donor strengths and steric and electronic properties 
that could easily be manipulated by varying the sustituents. In general, the 
functionality of benzimidazole can be take place in two ways: on the 
benzimidazole ring (4-, 5-, 6- or /and 7- positions) or on the N atoms (1- or/and 3- 
positions) of the heterocycle (Figure 1.11). The former type doed not coordinate to 
the silver center but in contrast, the latter, does so in different modes, depending on 
the nature of the heteroatoms.
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Figure 1.11: The possibilities to place the functionalities in benzimidazole and 
imidazole groups. 
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 Oxygen-functionalized benzimidazolium salts and their corresponding 
silver(I)-NHC complexes (1.19-1.23) have been investigated by Özdemir and co-
worker since recent years (Figure 1.12). These ether- and O-heterocycle-
functionalized benzimidazolium halides and their silver(I)-NHC complexes were 
then tested for their antimicrobial studies and it showed good result for this group 
research. The antimicrobial activities result for their silver complexes also varied 
according to the etherel, alkoxy, or O-heterocycle substituent because of their 
different lipophilicities. Although the mechanism was not well developed, it is 
believed that the functionalized substituent on the nitrogen atoms of the 
benzimidazole ring might disturb the intermolecular interaction of the bacteria and 
causing the breakage of bilayered bacterial cellular membranes.
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(a)        (b) 
Figure 1.12: Silver(I)-NHC complexes bearing (a) Ether-functionalized (1.19-
1.21); (b) O-heterocycle-functionalized (1.22, 1.23) benzimidazolium ligand by 
Özdemir and co-worker.
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Nitrogen-functionalized benzimidazolium salts and their silver(I)-NHC 
complexes also exhibited a good antibacterial and anticancer entities. Yiğit and co-
workers reported a series of amine-functionalized substituted benzimidazolium 
chlorides and their silver(I)-NHC complexes, for example (1.24) (Figure 1.14). All 
the salts and complexes were evaluated againts several bacteria and fungi. The 
silver(I)-NHC complexes proved to have potent antimicrobial activities.
86 
 
N
N
AgCl
H3C
N(CH3)2
 
(1.24) 
Figure 1.13: Example of amine-functionalized silver(I)-NHC complex, (1.24) by 
Yiğit and co-workers.86 
 
Haque and co-workers were synthesized nitrile-functionalized class of 
imidazole and benzimidazole with their metal-NHC complexes. A number of 
mono- (eg. 1.23) and dinuclear silver(I)-NHC complexes (eg. 1.24) of this class of 
compounds have been synthesized and furthermore, their DNA-binding studies,
87,88
 
antibacterial,
89 
anticancer
63,90,91
 and catalytic studies
50 
were successfully 
investigated (Figure 1.14). The nitrile functionality on these ligands provided an 
extra space for bonding or bridging to silver(I) centre and this unique ability gave 
benefit either in coordination or in the formation of supramolecular architecture.
63 
21 
 
Other than that, the binding effect due to interaction or coordination between the 
nitrile functionality and the silver(I) centre can result in more stable silver(I)-NHC 
complexes that can slowly release silver ions at the wound site, thus preserving the 
antibacterial effect over a longer time.
92
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X = Br, PF6, BF4
(1.25)
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(b) 
Figure 1.14: Examples of nitrile-functionalized of (a) mono
88
 (1.25) and (b) 
dinuclear
90
 (1.26) benzimidazolium silver(I)-NHC complexes by Haque and co-
workers 
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1.9 Conclusions 
 N-heterocyclic carbenes (NHC) were receiving more attention these few 
years due to their abilities in many fields such as catalysis and biological activities. 
Silver(I)-NHC complexes, unlike other metal-NHC, can be synthesized and 
isolated easily. Hence, NHC ligand salts with variety substituents were synthesized 
widely and their structural study has led to a diverse field of bonding motifs in 
solid state. Silver(I)-NHC displayed an excellent ability in biological activities and 
also in the transmetalation to other metal NHC.  
 
1.10 Objectives of the studies 
The objectives of this project are: 
i. To synthesise N-heterocyclic carbenes (NHC) ligands based on 
benzimidazolium with different substituents to produce whether non-
functionalized or nitrile-functionalized compound. 
ii. To synthesise novel silver(I)-NHC complexes containing the NHC ligands. 
iii. To synthesise novel palladium(II)-NHC complexes using silver(I)-NHC 
complexes as transfer agents. 
iv. To characterize all the synthesized ligand salts and complexes using 
different spectral and analytical methods. 
v. To prove the proposed structures for the synthesised compounds using 
single crystal X-ray diffraction analysis/crystallography. 
vi. To evaluate the antibacterial activities of benzimidazolium salts and metal-
NHC complexes. 
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1.10.1 Targeted benzimidazolium salts 
 For this project, benzimidazole was used instead of imidazole because of its 
medicinal importance. The targeted ligand salts are monodentate and bidentate 
benzimidazolium salts bearing one substituent of benzyl with different substituent 
at different positions as their PF6
-
 salts. All the prepared salts were characterized 
using spectral and analytical methods. The structural properties were confirmed by 
using single crystal X-ray diffraction techniques. These will be discussed briefly in 
Chapter 3 and 4. 
 
1.10.2 Targeted metal 
The synthesised benzimidazolium salts were used as the NHC ligand 
precursors to produce mononuclear and dinuclear silver(I)-NHC complexes. The 
silver(I)-NHC complexes were then used to produce palladium(II)-NHC 
complexes. 
 Silver(I)-NHC complexes became the primary interest for this project 
because easy to prepare starting from silver(I) oxide and their potential biological 
activities. Silver(I)-NHC complexes are known to be useful carbene transfer 
reagents and the silver(I)-NHC complexes may serve as synthetic precursors for 
palladium(II) complexes through their reaction with any palladium metal source 
especially Pd(COD)Cl2 (where COD= 1,5-cyclooctadiene) in this project. The 
detailed information about silver(I)-NHC and palladium(II)-NHC complexes will 
be discussed in Chapter 3 and 4 respectively. 
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CHAPTER 2 
EXPERIMENTAL 
 
2.1 Materials 
 Benzimidazole (Merck, for synthesis), 2-bromopropane (Merck, for 
synthesis), 1,4-dibromobutane (Sigma Aldrich, 99%), 2-methylbenzyl bromide 
(Sigma Aldrich), 3-methylbenzyl bromide (Sigma Aldrich, 96.0%), 4-methylbenzyl 
bromide (Sigma Aldrich, 97.0%), 2-(bromomethyl) benzonitrile (Merck, for 
synthesis), 3-(bromomethyl) benzonitrile (Merck, for synthesis), 4-(bromomethyl) 
benzonitrile (Sigma Aldrich, 99.0%), potassium hydroxide pellets (R&M 
chemicals, 85%), potassium hexafluorophosphate (Across Organic, 99.0%), 
silver(I) oxide (Merck, 99.0%), dichloro(1,5-cyclooctadiene)palladium(II) (Sigma 
Aldrich), Celite (Merck, size: 0.02-0.1 mm), dimethyl sulphoxide (DMSO) 
(QRëC), chloroform (QRëC), 1,4-dioxane (QRëC), methanol (QRëC), acetonitrile 
(QRëC), and diethyl ether (QRëC) were purchased from commercial sources and 
were used as received without any further purification. The reagents, N-(2’-
propyl)benzimidazole and N,N’-(1,4-diyl-butane)bisbenzimidazole were 
synthesized according to the literature procedure
94,113
 with slight modifications. 
 
2.2 Instruments 
 The melting point was tested using a Stuart Scientific SMP-1 (UK) 
instrument. Elemental analysis was carried out on a Perkin Elmer Series II, 2400 
microanalyzer. The fourier transforms infrared (FT-IR) spectra were recorded in 
potassium bromide disks using a Perkin Elmer 2000 system spectrometer in the 
range of 4000 cm
 
to 400 cm
-1
. Nuclear magnetic resonance (NMR) spectra were 
